BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
2.070
+0.055 (2.73%)
At close: May 26, 2026, 4:00 PM EDT
2.150
+0.080 (3.86%)
After-hours: May 26, 2026, 6:16 PM EDT

BioNexus Gene Lab Revenue

BioNexus Gene Lab had revenue of $22.84K in the quarter ending March 31, 2026, a decrease of -98.93%. This brings the company's revenue in the last twelve months to $5.31M, down -42.69% year-over-year. In the year 2025, BioNexus Gene Lab had annual revenue of $7.42M, down -21.93%.

Revenue (ttm)
$5.31M
Revenue Growth
-42.69%
P/S Ratio
0.94
Revenue / Employee
$279,509
Employees
19
Market Cap
5.00M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.42M-2.09M-21.93%
Dec 31, 20249.51M-260.16K-2.66%
Dec 31, 20239.77M-1.16M-10.60%
Dec 31, 202210.93M-2.43M-18.21%
Dec 31, 202113.36M1.97M17.31%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition